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The biolipid sphingosine-1-phosphate (S1P) is an essential modulator of innate immunity, cell migration, and wound healing. It is
released locally upon acute tissue injury from endothelial cells and activated thrombocytes and, therefore, may give rise to acute post-
traumatic pain sensation via a yet elusive molecular mechanism. We have used an interdisciplinary approach to address this question,
and we find that intradermal injection of S1P induced significant licking and flinching behavior in wild-typemice and a dose-dependent
flare reaction in human skin as a sign of acute activation of nociceptive nerve terminals. Notably, S1P evoked a small excitatory ionic
current that resulted in nociceptor depolarization and action potential firing. This ionic current was preserved in “cation-free” solution
andblocked by the nonspecific Cl channel inhibitor niflumic acid andby preincubationwith theG-protein inhibitor GDP--S. Notably,
S1P3 receptor was detected in virtually all neurons in human andmouse DRG. In line with this finding, S1P-induced neuronal responses
and spontaneous pain behavior in vivo were substantially reduced in S1P3
/mice, whereas in control S1P1 floxed (S1P1
fl/fl) mice and
mice with a nociceptor-specific deletion of S1P1
/ receptor (SNS-S1P1
/), neither the S1P-induced responses in vitro nor the S1P-
evoked pain-like behavior was altered. Therefore, these findings indicate that S1P evokes significant nociception via G-protein-
dependent activation of an excitatory Cl conductance that is largely mediated by S1P3 receptors present in nociceptors, and point to
these receptors as valuable therapeutic targets for post-traumatic pain.
Introduction
Ongoing pain regularly results as a consequence of surgical inter-
ventions or trauma. Although this represents a major clinical
problem and severely affects the patients’ recovery, pain relief
strategies so far are restricted to the classical opioids or nonopioid
analgesics. To develop better strategies based on mechanistic in-
sight, the sequelae of mediators and interactions of injured tissue
with the nociceptive system leading to postoperative pain need to
be elucidated. Upon tissue injury and damage to blood vessels,
vascular leakage, accumulation, and activation of thrombocytes
and plasma extravasation occur. Injection of plasma and experi-
mentally activated thrombocytes excite nociceptors and induce
pain (Armstrong et al., 1957; Ringkamp et al., 1994). Human
platelets contain high concentrations of sphingomyelin-derived
sphingosine-1-phosphate (S1P), which can be released upon ac-
tivation and shape change (Dahmet al., 2006;Ulrych et al., 2011).
In blood plasma, S1P levels may reach up tomicromolar concen-
trations, most of which is bound to plasma proteins (Murata et
al., 2000; Schmidt et al., 2006; Ohkawa et al., 2008). S1P acts as a
lipid growth factor and induces robust endothelial cell activation,
resulting in cellular locomotion, vascularmaturation, and angio-
genesis (Daum et al., 2009). Furthermore, S1P has a general role
in postoperative wound healing via either intracellular mode of
action or specific targeting of metabotropic membrane receptors
(Vogler et al., 2003; Watterson et al., 2007). In general, S1P is the
natural ligand of five different G-protein-coupled receptors (GP-
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CRs S1P1-S1P5) that are expressed in various tissues, including
neurons and nociceptors (Spiegel and Milstien, 2003; Herr and
Chun, 2007; Chi and Nicol, 2010; Mair et al., 2011). Exogenous
S1P enhances the excitability of DRG neurons, potentiates heat-
sensitive transducer channels and modifies nociceptor heat sen-
sitivity via neuronally expressed S1P1 receptor (Mair et al., 2011).
In addition, this receptor has been associated with opioid-
induced hyperalgesia (Muscoli et al., 2010; Mair et al., 2011).
Because local increases in S1P levels arise fromacute tissue injury,
damage to blood vessels and activation of platelets after traumaor
surgical procedures, we hypothesized that S1Pmay have a signif-
icant role in the mechanism causing post-traumatic pain. In this
paper, we address this issue with an interdisciplinary approach
and investigate S1P-induced nociceptor excitation in a cellular
model. In addition, the relevance of this finding is addressed in
vivo in mice and humans.
Materials andMethods
Ethics statement. All animal experiments have been performed with
permission of the Austrian Bundesministerium fu¨r Wissenschaft und
Forschung (BMWF) ministry (BMWF-66.011/0051-II/10b2008;
BMWF-66.011/0113-II/3b/2010; GZ 66.011/85-C/GT/2007) and ac-
cording to ethical guidelines of the IASP (International Association for
the Study of Pain) (Zimmermann, 1986).
Flinching and licking measurement. All behavioral measurements were
done in age-matched awake, unrestrained, male C57BL/6J mice ( 8
weeks old) by individuals who were blinded to the genotype of the mice
being analyzed. Spontaneous pain-like behavior was monitored after in-
tracutaneous injection of S1P (15 l, 500 M) or vehicle (15 l, 10%
methanol in PBS) into the left hindpaw of wt, S1P3
/, S1P1
fl/fl, or
SNS-S1P1
/ mice, which selectively lack the S1P1 receptor subtype in
Nav1.8 channel-expressing nociceptive neurons (Mair et al., 2011).Mice
were placed in the plastic chamber and allowed to habituate for at least
1 h before the experiment. Flinching and licking behavioral responses
were scored over a 30 min period after injection. When mice rapidly
shook their hindpaw, it was scored as a positive flinching response and
then the number of flinches was assessedmanually. Licking behavior was
assessed by counting manually the number of licks and the overall dura-
tion of all scored licks.
Mousemodel of incisional plantar pain.Allmice were anesthetized with
ketamine (2 mg/kg) and xylasol (0.2 mg/kg) (both from Ogris Pharma).
The plantar aspect of the hindpaw was disinfected with polyvidone-
iodine solution (Wundesin, Gebro Pharma) and a 1-cm-longitudinal
incision wasmade with a sterile surgical blade (no. 10), through skin and
fascia of the plantar aspect of the paw, starting 0.5 cm from the proximal
edge of the heel and extending toward the toes. The plantaris muscle was
also incised longitudinally. The skin was sutured with two thread of 5-0
polypropylene on a TF needle (Prolene, Ethicon, Johnson & Johnson
Medical Products) and the wound covered with Wundesin. The sutures
were removed under anesthesia on postoperative day 2, and typically
wounds healed within 5–6 d.
Heat sensitivity. Heat sensitivity was assessed using the Hargreaves test
(Hargreaves et al., 1988). A radiant heat source delivering an increasing
heat stimulus was focused under the plantar surface of the hindpaw. The
time from initiation of the radiant heat until paw withdrawal (paw with-
drawal latency [PWL] in seconds) was measured automatically with an
algesiometer (Ugo Basile). Each hindpaw was tested at least three times,
and the mean withdrawal latency was calculated. The time interval be-
tween two trials on the same hindpaw was at least 1 min.
Mechanical sensitivity.At least 1 h before testing, mice were placed in a
Plexiglas chamber (10.5  10.5  14 cm) with a metal grid floor. Me-
chanical sensitivity was testedmanually before and after surgery by using
calibrated von Freymonofilamentswith defined bending forces (1.4, 4, 8,
16, 22.6, 32, and 45.3 mN). Two baseline measurements were taken at 2
and 1 d before surgery. Each filament was applied five times with at least
60 s between applications. Data are expressed as the percentage of paw
withdrawals in response to each filament (mechanical response fre-
quency). Positive responses were counted when the paw was sharply
withdrawn and flinching of the paw was observed immediately after
removal of the filament. All othermovements of the pawwere considered
as unclear responses, and the stimulus application was repeated.
Transgenic mice. Global S1P3 receptor null mutant mice (S1P3
/)
and mice homozygous for the floxed exon 2 allele of the S1P1 receptor
gene (S1P1
fl/fl), which encodes for the entire receptor protein, have been
described previously (Allende et al., 2003; Kono et al., 2004). S1P1
fl/fl
mice were cross-bred with SNS-Cre-mice (Agarwal et al., 2004) to obtain
homozygous SNS-Cre:S1P1
fl/fl (hereinafter referred to as SNS-S1P1
/)
and S1P1
fl/fl mice (control littermates; the Cre-recombinase is homozy-
gous or heterozygous) as previously published (Mair et al., 2011).
Flare-reaction measurement. Five healthy subjects (1 woman and 4
men;mean age 32 years; range, 23 years) participated in this randomized,
double-blinded study. Each subject was informed and gave written con-
sent to take part in the study; the experimental protocol was approved by
the Ethics Committee of the Medical Faculty of Mannheim of the Uni-
versity Heidelberg. Vehicle solution (saline, 15% cyclodextrin) and S1P
(100 l of 0.125, 0.25, 0.5, and 1 mM) were injected in the central volar
forearm at distances of 4 cmbetween the injection sites. Superficial blood
flow around the injection site was assessed before the injection and im-
mediately thereafter repeatedly in 4 min intervals using a laser-Doppler
imager (Moor Instruments). An area of 9 34.5 cm around the injection
sites was scanned. The area of the axon-reflex erythema was determined
as the number of cm2 increasing 2-fold compared with the baseline
scan by dedicated software (Moorldi Version 5.0, Moor Instruments).
Pain scores were assessed for the injections of S1P and vehicle (saline,
15% cyclodextrin); however, the pain upon injection did not differ sig-
nificantly between vehicle and S1P and there was no lasting pain sensa-
tion after retraction of the cannula (data not shown).
Primary sensory neuron culture. Lumbar (L1-L6) DRG with the cell
bodies of primary afferents that project into the hindpaw were harvested
from adult C57BL/6J or transgenic mice and dissociated as previously
published (Mair et al., 2011). Briefly, ganglia were treated enzymatically
with collagenase (Liberase, Roche) and trypsin-EDTA (Invitrogen), and
dissociatedmechanically with a fire-polished Pasteur pipette. The result-
ing cell suspension was washed, plated on glass coverslips coated with
poly-L-lysine/laminin (Sigma) and cultivated in synthetic, serum-free
medium (supplemented TNB, Biochrom) supplemented with nerve
growth factor (NGF; 100 ng/ml) at 37°C in 5% CO2 in a humidified
incubator for 18–32 h.
Electrophysiology.Using the whole-cell voltage-clamp configuration of
the patch-clamp technique, ionic currents were recorded from isolated
neurons at a holding potential of80 mV as previously published (Ob-
reja et al., 2002, 2005). The external control solution (ECS-low Ca2)
contained the following (inmM): 150NaCl, 5KCl, 0.1CaCl2, 1MgCl2 (all
Sigma), 10 glucose and 10 HEPES (Merck), at pH 7.3 adjusted with
NaOH (Merck). Borosilicate glass micropipettes (Science Products)
pulled with a horizontal puller (Sutter Instruments) were filled with
internal solution (ICS, in mM): 148 KCl, 2 MgCl2, 2 Mg-ATP, 0.2 Na-
GTP, 0.1 CaCl2, 1 EGTA (all Sigma) and 10 HEPES (Merck), at pH 7.3
adjusted with KOH (Merck). After filling, electrode resistance was 2.5–
3.5 M. Currents were filtered at 2.9 kHz, sampled at 100 Hz, and re-
corded using an EPC-9 (HEKA) and the Pulse Version 8.74 software
(HEKA). The “cation free” extracellular solution contained the following
(in mM): 163 NMDG, 5 EGTA, 10 HEPES, 10 D-glucose, 1 MgCl2 at pH
7.3 adjusted with HCl (Merck). The membrane potential was recorded
Table 1. Antigen characteristics
Antigen Host Dilution Source
S1P2 (directed against C-terminus) Rabbit 1:100 S. Mandala
S1P3 (directed against N-terminus) Rabbit 1:100 S. Mandala
NF200 Mouse, clone N52 1:1000 Sigma
I-B4 Bandeira simplifolicia 1:1000 Sigma
Secondary antisera
Cy3 anti-rabbit Ig Donkey 1:100 Jackson
Cy5 anti-mouse Ig Donkey 1:50 Jackson
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using current-clamp configuration (Ihold  0
pA) using an ECS containing the following (in
mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2 (all
Sigma), 10 D-glucose and 10 HEPES (Merck),
at pH 7.3 adjusted with NaOH (Merck). The
pipette solution was composed (in mM) of 45
KCl, 98 K-gluconate, 0.5 CaCl2, 5 EGTA, 10
HEPES, 2MgATP, 0.2NaGTP, pH7.3 adjusted
with KOH (Merck). The membrane potenial
was sampled at 4 kHz. Experiments were per-
formed at room temperature (22°C), and
only a single neuron was tested per coverslip.
An automated seven-barrel system with com-
mon outlet at 100 m distance of the recorded
cell was used for fast S1P administration (Dit-
tert et al., 1998).
Microfluorimetric calcium measurements.
Cells were plated on glass-bottom dishes
coated with poly-L-lysine hydrobromide (10
g/ml) and laminin (10 g/ml) (both from
Sigma). One day cultured cells were incubated
with 3 M of the calcium (Ca2) sensitive dye
Fura-2-acetoxymethyl ester (Invitrogen) in
ECS consisting of the following (in mM): 145
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose
(all from Sigma) and 10HEPES (Merck), at pH
7.3 adjusted with NaOH (Merck) and were in-
cubated for 25 min at 37°C in 5% CO2, in a
humidified incubator. Then cells were washed
twice with PBS (PAA) and finally kept in ECS
for experiments. For the Ca2-free solution,
CaCl2 was replaced by 5 mM EGTA. Ca
2 re-
cordings were performed using an Olympus
IX71 microscope (Olympus) with a 20/0.85
N.A. oil-immersion objective (Olympus).
Fura-2 was excited consecutively at 340 and
380 nm (excitation time: 25 ms) with a poly-
chrome IVmonochromator (TILL Photonics),
and fluorescence intensities were filtered by a
510 nm LP filter and recorded with a CCD
camera (TILL Photonics). The changes of in-
tracellular Ca2 concentration [Ca2]i are de-
picted as ratio of fluorescence intensities
collected at 340 nm and 380 nm (F340/380)
at a time interval of 1 s (Linhart et al., 2003).
For data acquisition, MetaFluor4.6r8 (Univer-
sal Imaging) was used and off-line analysis was
performed with OriginPro7.SR2 (Origin Lab).
The threshold for S1P-positive cells was set to fourfold the SD of the
Ca2 signal evoked by 0.1% methanol (F340/380  0.04). All chemi-
cals were purchased from Sigma.
Immunohistochemistry.MurineDRGswere dissected, fixed in Zambo-
ni’s fixative for 24 h, dehydrated through a graded series of etha-
nol and DMSO, and subsequently embedded in polyethylene glycol
(1450 MW: Sigma-Aldrich) (Murphy et al., 1998). DRGs were sectioned
at 12mand stored in PBS containing 0.01% sodium azide at 4°C before
multiple-labeling immunohistochemistry. Free-floating sections were
blocked using 10%normal donkey serumand incubated for 48 hwith the
S1P3 antiserum (a generous gift from S.Mandala). After washing in PBS,
the sections were incubated for 2 h with secondary antiserum (Cy3-
labeled donkey anti-rabbit IgG, Jackson ImmunoResearch Laborato-
ries), washed in PBS, and coverslipped in buffered glycerol. Likewise,
indirect immunofluorescence was performed in cultured neurons fixed
in Zamboni’s fixative for 2 h and stored in PBS.
Human DRGs (N 2) were obtained from the South Australian and
Victorian Brain Bank frommotor neuron disease patients 12–16 h post-
mortem. DRGs were immersion fixed in Zamboni’s fixative for 24–72 h.
The use of human material was approved by the Flinders Clinical Re-
search Ethics Committee. HumanDRGswere embedded in polyethylene
glycol as described previously (Murphy et al., 1998), cut at a thickness of
10 m, and the free floating sections were incubated for 48 h with S1P3
antiserum. After washing in PBS, the sections were incubated overnight
with secondary antiserum, washed in PBS, and coverslipped in buffered
glycerol. Images were taken using a confocal laser scanning microscope
(Leica SP5).
Immunocytochemistry. DRG neurons were cultured on coverslips,
fixed for 2 h in Zamboni’s fixative, washed in PBS, and incubated with
primary antisera overnight, followed by washing and 1 h incubation with
secondary antisera. Finally, the coverslips were washed in PBS and cov-
erslipped in buffered glycerol (Mair et al., 2011). Preabsorption of the
S1P3 antiserum with the corresponding antigen led to the absence of
staining (Table 1).
mRNA in situ hybridization. The protocol used was modified from an
earlier method used by Obernosterer et al. (2007). Cryostat sections of
mice lumbar DRGs were fixed with Zamboni’s fixative for 24 h, washed
in PBS, digested with proteinase K (2 mg/ml), fixed with 4% PFA, acety-
lated (triethanolamine/HCl/acetic anhydride), and incubated with pre-
hybridization buffer. Target mRNAs were hybridized with 0.34 pmol of
specific antisense double digoxigenin-labeled mRNA detection probes
(S1P3, 5DigN/ACTGATGAGGAAGGCGATGTAT/3Dig_N) or scram-
Figure 1. Contribution of S1P to pain-like behavior inmice and axon reflex in humans. Intracutaneous injection of S1P into the
ipsilateral hindpaw of wt mice significantly enhanced the number of flinches (A), licks (B), and increased the time of licking
response during 10min upon administration (C) (N 7–10mice).D, Specimen (before and 4min after S1P injections) of the flare
reaction recorded by laser Doppler imaging indicating an increased blood flow by lighter colors (flux in arbitrary units [AU], and in
a pseudo-color scale) after intradermal injection of increasing concentrations of S1P (100l of 0.125, 0.25, 0.5, 1mM) and vehicle
(100l, saline, 15% cyclodextrin). Larger flare areas were developed around the injection sites of the two highest concentrations
(red arrows). E, Quantitative analysis of the flare reaction area produced by S1P in human skin by repeated laser-Doppler images of
the flare profile. The graph represents the time course of the axon reflex flare development (flare area in cm 2) around the injection
sites of vehicle and S1P (injection after minute 1) at 4 min intervals. *p	 0.05. **p	 0.01. ***p	 0.001.
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bled probes (Exiqon) or hybridization buffer as negative controls
(Obernosterer et al., 2007) overnight at 55°C. Washing with sodium–
saline citrate was followed by blocking and overnight incubation with
alkaline phosphatase-coupled anti-digoxigenin antiserum. Incubation
with secondary antisera for 1 h was followed by washing in PBS. Slides
were coverslipped in buffered glycerol and images taken using an epiflu-
orescence microscope (BX50, Olympus). Subsequently coverslips were
removed, and the sections incubated with BCIP/NBT (Roche) to visual-
ize S1P3 receptor mRNA.
Data analysis and statistics. Statistical analysis was performed per ani-
mal (N) and per number of cells (n) for the patch-clamp and calcium
imaging data. For detailed statistical analysis, the Sigma Stat 3 and
GraphPad Prism 5 software were used, and the data are presented as
mean
 SEM. Statistical tests were used depending on sample size, dis-
tribution, and number of variables: two-way repeated-measures (RM)
ANOVAwith post Tukey test, the nonparametricMann–WhitneyU test,
or the parametric unpaired two-sided t test for comparison between
groups; for intraindividual comparisons, the Wilcoxon matched-pairs
signed-rank test or the parametric Student’s paired t test was used. Fish-
er’s test was used where stated. Differences were considered statistically
significant at p	 0.05.
Results
S1P evoked pain-like behavior in mice and flare-reaction
in humans
To determine whether S1P was involved in the spontaneous pain
induction in vivo, we examined flinching and licking responses in
wt mice after S1P intradermal injection. We measured the num-
ber of flinches for 10 min after S1P (500 M, 15 l) or vehicle
(10% methanol in PBS, 15 l) injection into the left hindpaw
(ipsilateral) of wt mice. Interestingly, we found that upon S1P
injection mice developed a significant increase in the number of
flinches (4.9
 2.02 compared with vehicle, p 0.0007, Mann–
Whitney U test, N  10 mice per condi-
tion, Fig. 1A). This was accompanied by
an increase in S1P-induced number of
licks (5.31
 1.53 S1P-injected vs vehicle-
injected mice, p  0.0011, Mann–Whit-
neyU test,N 7 mice per condition, Fig.
1B) and licking time (26.14
 8.27 s com-
pared with vehicle, p  0.001, Mann–
WhitneyU test,N 7mice per condition,
Fig. 1C). No effect on flinching and licking
behavior was observed in vehicle-injected
control mice (Fig. 1A–C) or at lower S1P
doses (10 and 100 M; data not shown).
Furthermore, in control experiments,
methanol did not produce any depolariza-
tion, Ca2 rise, or pain-like behavior up to
concentrations of 10%. These data indicate
that S1P can evoke acute spontaneous pain-
like behavior in vivo.
To investigate whether these findings
bear relevance to pain-related behavior in
humans, increasing doses of S1P (0.125,
0.25, 0.5, and 1 mM) were injected intrad-
ermally. As objective assessment of skin
nociceptor excitation the increase of skin
blood flow (in pixels) and the correspond-
ing size of the axon-reflex flare area (in
cm2) around the different injected sites
were monitored with laser Doppler imag-
ing. Cutaneous S1P challenges produced a
dose-dependent flare response by increas-
ing the blood flow in the skin immediately
after injection (increased intensity in arbi-
trary units is indicated by red arrows in Fig. 1D, right). Pain
scores were assessed for the injections of S1P and vehicle (saline,
15% cyclodextrin); however, the pain upon injection did not
differ significantly between vehicle and S1P, and there was no
longer lasting pain sensation after retraction of the cannula (data
not shown). S1P provoked a massive increase of the axon reflex-
mediated blood flow showing the most pronounced effect at 0.5
and 1 mM concentration at 4 min after injection (flare area 
5.82 
 0.95 cm2 and 8.58 
 1.16 cm2, respectively) that was
significantly higher compared with the vehicle-injected site (flare
area 2.23
 0.28 cm2) (p 0.0000113 compared with 0.5 and
1 mM S1P-injented subjects within the time, two-way RM
ANOVA with post Tukey test, N 5 subjects; p 0.0079 for 0.5
mM S1P vs vehicle at 4 min after injection, p 0.0079 for 1 mM
S1P vs vehicle at 4min after injection,Mann–WhitneyU test, Fig.
1E). The S1P-evoked flare response was detectable until 12 min
after injection, indicating a long-lasting effect of S1P on skin
vasodilatation (Fig. 1E). These results support the hypothesis that
S1P has a significant role in spontaneous pain behavior indicated
by pain like-behavior in mice and skin flare reaction as a sign of
nociceptor activation in humans.
S1P-inducedmembrane depolarization and generation of
action potentials in neurons
In the whole-cell current-clamp configuration of the patch-
clamp technique, exposure of single dissociatedmouseDRGneu-
rons to S1P (1 M, 10 s) induced a significant membrane
depolarization from a resting membrane potential of 54.39 

1.02 mV (Ctrl) to 35.68 
 1.99 mV (S1P) in n  34 neurons
tested (p 0.0001, t(33) 10.297, paired t test, N 3 mice each
Figure 2. Effect of S1P on the membrane potential in murine DRG neurons. A, B, Short application of S1P (1 M, 10 s)
depolarized DRG neurons by changing themembrane potential (Em) from54.4
 1.0mV in control (Ctrl) condition to36

2mV in the presence of S1P. The Em recovery valuewasmeasured 10min after S1P application (50
 1mV). C,D, Most neurons
(64.7%) generated APs in response to S1P (1M, 10 s) with a mean firing rate of 1.7
 0.4 AP s1. ***p	 0.001.
Camprubí-Robles et al. • S1P Induces Spontaneous Pain J. Neurosci., February 6, 2013 • 33(6):2582–2592 • 2585
Archived at Flinders University: dspace.flinders.edu.au
condition, Fig. 2A,B). Depolarizationwas
sufficient to induce firing of action po-
tentials (APs) upon S1P stimulation in
22 of 34 neurons [64.7%] (fAP 1.67

0.04 s1, p 0.0000004768, T 253,
Wilcoxon matched-pairs signed-rank
test, Fig. 2C,D). Both depolarization
and AP discharge recovered to pre-
stimulation values within 10 min of
washout (recovery Em49.94
 1.23
mV vs S1P application, p  0.0000511,
t(32) 8.357 and recovery fAP 0.076

0.068 s1 vs S1P application, p 
0.00002384, T  8, respectively).
These results suggest a direct excitatory
effect of S1P on primary afferent
neurons.
S1P-induced slowly activating and
slowly inactivating excitatory
ionic conductance
Using the whole-cell voltage-clamp con-
figuration of the patch-clamp technique,
we observed that S1P (1 M, 10 s) gener-
ated currents with an amplitude of
0.538
 0.036 nA (n 34 cells, Fig. 3A) in
most sensory neurons. S1P-evoked cur-
rents reached a maximum value after
100.4 
 4.14 s (n  57 cells) and were
slowly deactivating (  177.90 
 15.16
s). S1P-activated currents increased in a
dose-dependent manner with an EC50 of
0.160 M (Fig. 3B).
Because S1P reportedly increases
intracellular calcium concentrations
([Ca2]i) (Hopson et al., 2011), we hy-
pothesized that excitatory currents were
at least partially carried by Ca2 (and
Na) ions. We performed Fura-2-based
Ca2 imaging on cultured neurons and
found that S1P-induced [Ca2]i rises in
182 of 308 [59.1%] neurons (Fig. 3C top,
D). Neurons usually responded to S1P
within 15 s, and mean ratio amplitudes of
evoked Ca2 responses were F340/
380 0.14
 0.01 (N 6 mice, n 308
cells, Fig. 3E). To determine the Ca2
source of S1P-induced [Ca2]i elevation,
Ca2 measurements were performed in
Ca2 free solution (5 mM EGTA), and
we found S1P-induced Ca2 transients
fully abrogated (F340/380  0.0043 
 0.0005; p  0.00002 vs
S1P, t(126) 8.791, unpaired t test,N 3mice each, n 127 cells,
Fig. 3C bottom, D,E). These results were further corroborated by
recordings from isolated DRG neurons after depletion of intra-
cellular Ca2 stores with thapsigargin (TG), an inhibitor of the
endoplasmic reticulum Ca2-ATPase SERCA (Rogers et al.,
1995). Cultured neurons exposed to TG (1 M, 5 min) did not
show any Ca2 alteration mediated by high potassium-induced
depolarization (data not shown). As expected, the percentage
of S1P reacting neurons was unchanged (79 of 136 responders
[58.1%]; p  0.917, Fisher’s test, Fig. 3D) and neuronal re-
sponses to S1P after TG treatment (F340/380 0.12
 0.01)
were similar to untreated controls (p  0.264, Fisher’s test,
N  4 mice, n  136 cells, Fig. 3E). Together, these data
suggest that S1P-evoked Ca2 transients are the result of a
Ca2 influx rather than a release from intracellular stores.
S1P-activated chloride conductance in primary
sensory neurons
To determine the relative contribution of cations to the overall
current induced by S1P, whole-cell voltage-clamp recordings
were performed using “cation-free” external solution (0 Na, 0
K, and 0 Ca2). Surprisingly, we observed that the S1P-evoked
current was fully preserved in “cation-free” ECS (IS1P: 6.18 

Figure 3. Ionic nature of the excitatory currents induced by S1P. A, Typical recording of a responsive neuron after a short pulse
of S1P (1M, 10 s). B, The graph shows the dose–response relationship of the S1P-induced conductance. The EC50 was 0.160M
S1P. C, Top, Representative Ca 2 imaging measurement of the S1P-evoked Ca 2 transient in DRG neurons in ECS (containing 2
mM Ca 2). Bottom, The Ca 2 rise induced by S1P was completely abolished in Ca 2 free condition (5 mM EGTA,3.5 min
exposure) but lightly recovered after washout (2 min). D, E, A small change in [Ca 2]i induced by short application of S1P (1M,
60 s)was observed inmostDRGneurons. In presence of TG (1M, 5min), thepercentageof S1P-respondingneurons and the Ca 2
increasemagnitude was not significantly different from control conditions. For each Ca 2measurement, 25–30 neurons (N 3
mice) were randomly selected in the field. F, Top, Whole-cell recording from S1P-activated current in “cation free” condition (0
Ca 2, 0 K, 0Na, 1min). Bottom,Quantificationof theS1P-induced current density for recordings inF that remainedunaltered
after neuron exposure to “cation free” solution (3 min after S1P application). n.s., Not significant ( p 0.05). ***p	 0.001.
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1.08 pA/pF control vs 5.85
 1.38 pA/pF after 1min “cation free”;
p 0.138, t(15) 1.568, paired t testN 3mice, n 18 cells, Fig.
3F). This result indicated that excitatory currents were not car-
ried by cations and that Ca2 influx was likely the result of
voltage-gated Ca2 channel activation secondary to the Ca2-
independent membrane depolarization. Because chloride (Cl)
channels have been associated with the activation of ionic cur-
rents by S1P in neuroblastoma cells (Postma et al., 1996), elec-
trophysiological and microfluorometric Ca2 measurements
were performed in the presence of the nonspecific Cl channel
blocker niflumic acid (NFA). We found significant inhibition of
IS1P by NFA by reducing the deactivation time constant () from
177.90
 15.16 s in control to 44.46
 5.38 s with NFA (100 M)
(p 0.000100839, T 36, Mann–Whit-
ney U test, N 3 mice each, n 18 cells,
Fig. 4A,B). Moreover, incubation with
NFA (100 M, 9 min) almost fully pre-
vented S1P-evoked Ca2 transients
(F340/380  0.023 
 0.003, p 
0.0000021, t(434)  7.581, unpaired t test,
N 4 mice each, n 128 cells, Fig. 4C,E)
and only 18 of 128 (14%) neurons still
responded to S1P (p  0.0000025, Fish-
er’s test, Fig. 4D). Both results support the
idea that Cl is the main ion carrying
S1P-induced currents in sensory neurons.
S1P-induced conductance and
excitation is reduced in S1P3
receptor-deficient neurons
Two possible mechanisms of activation
may account for S1P-induced current
activation: (1) S1P may act as a direct
ligand at a channel protein, or (2) chan-
nel gating may occur indirectly and re-
quires G-protein coupled S1P receptors.
To discriminate between both possibil-
ities, neurons were internally perfused
with GDP--S (a general G-protein in-
hibitor; 3 mM, 9 min). This treatment
fully abolished IS1P in DRG neurons,
suggesting a G-protein-dependent mech-
anism (p  0.0000015, T  11, Mann–
Whitney U test, N  3 mice, n  13
neurons, Fig. 4F).
At the moment, five G-protein-
coupled S1P receptors are known: S1P1
receptors were found predominantly ex-
pressed in small peptidergic and nonpep-
tidergic (isolectin B4-positive [I-B4])
sensory neurons, which are important in
regulating behavioral sensitivity during
inflammation (Chi and Nicol, 2010; Mair
et al., 2011). In addition, S1P2 and S1P3
mRNAs are also detected inDRGneurons
(Mair et al., 2011). To address expression
patterns for S1P receptors in certain neu-
ronal populations, indirect immunofluo-
rescence was performed with specific
antisera for S1P receptors, which were a
generous gift from S. Mandala, and cola-
beling with a marker for large nonnocice-
ptive neurons (Neurofilament 200
[NF200]). S1P2 receptor immunoreactivity was exclusively de-
tected in large (NF200) peptidergic neurons (Fig. 5A, top).
More importantly, S1P3 was the most abundant S1P receptor
expressed in virtually all small and large mouse DRG neurons
(Fig. 5A, bottom).
To first address the functional significance of the S1P1 recep-
tor in neuronal responses to S1P, we performedmicrofluorimet-
ric Ca2 measurements in DRG neurons from transgenic mice
with conditional deletion of S1P1 in nociceptive neurons (SNS-
S1P1
/). S1P-evoked Ca2 transients in neurons from SNS-
S1P1
/ (1 M, 60 s) were similar to those from S1P1
fl/fl mice
(p  0.9688, t(278)  0.03921, unpaired t test, N  3 mice per
genotype, Fig. 5B,C). This suggests that S1P1 receptor activation
Figure 4. Contribution of Cl to the ionic conductance of S1P-activated currents. A, B, Application of the nonspecific Cl
channel blocker NFA (100M, 5 min) drastically diminished the time constant () of S1P-evoked currents. C, Application of NFA
(100M, 9min) prevented the S1P-induced Ca 2 influx.D, Only 14% of neurons [18 of 128] responded to S1P in the presence of
NFA. E, S1P-induced Ca 2 response was fully inhibited by NFA. For each Ca 2measurement, 25–30 neurons from N 3 mice
were selected at random in the field. F, Incubation of DRG neurons with the general G-protein inhibitor GDP--S (3mM,9min)
fully blocked S1P-induced current density. ***p	 0.001.
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may not be quantitatively relevant in S1P-
induced pain-like behavior. This is fur-
ther supported by the small population of
S1P1-expressing neurons (Mair et al.,
2011), which was in obvious contrast to
the finding that IS1P could be evoked in
virtually all neurons. Nonetheless, S1P1
may contribute to neuronal responses to
S1P in the S1P1-expressing subpopulation
of sensory neurons.
In contrast to several reports sup-
porting a role for S1P1 in nociceptor
sensitization and hyperexcitability, the
significance of S1P3 receptors for nocice-
ption has so far not been addressed. To
first characterize S1P3 expression in sen-
sory neurons, we performedmRNA in situ
hybridization using riboprobes recogniz-
ing S1P3 receptor on mouse DRG sec-
tions. Distinct, specific signals over the
soma of virtually all large- and small-
diameter wt DRG neurons were obtained
(black arrows in Fig. 6A, left top). Control
scramble probes used in wt and S1P3
/
DRG sections (Fig. 6A, right top and bot-
tom) and the prehybridization buffer
(data not shown) did not yield any appre-
ciable signals. No S1P3 labeling was de-
tectable in neurons from S1P3
/ (Fig.
6A, left bottom). Importantly, S1P3 recep-
tor immunoreactivity was expressed in
virtually all small and large sensory neu-
rons in human and mouse DRG sections
(Fig. 6B). When we assessed S1P-induced
changes of membrane potential (Em) in
S1P3
/ neurons, we observed that S1P-
evoked depolarization was drastically de-
creased compared with wt neurons
(Em
S1P in S1P3
/  4.84 
 1.1 mV vs
wt 18.71
 2.1mV; p 0.00000379306,
T  351, Mann–Whitney U test, N  5
mice, n  28 neurons, Fig. 6C). In ratio-
metricCa2measurements, the number ofneurons responding to
S1P was decreased to 20% in S1P3
/ mice (p  0.0002 vs wt,
Fisher’s test,N 6mice,n 228neurons, Fig. 6D) andS1P-evoked
Ca2 transients were significantly diminished (S1P3
/ F340/
380 0.069
 0.006 vs wt 0.14
 0.01; p 0.00000013, t(622)
5.327, unpaired t test, Fig. 6E).Thesedata introduceS1P3 receptor as
a significant component of S1P-induced nociceptor excitation.
Spontaneous S1P-induced pain-like behavior is attenuated in
S1P3
/mice
Finally, we addressed the role of S1P receptors in the generation
of spontaneous pain in vivo. After intradermal injection of S1P,
licking and flinching behavior responses were similar between
SNS-S1P1
/ and S1P1
fl/fl mice (p  0.937, Mann–Whitney U
test,N 7 mice per genotype, Fig. 7A–C). In contrast, the num-
ber of flinches was substantially reduced in S1P3
/ mice com-
pared with wt littermates (0.40
 0.31 vs 4.9
 2.02; p 0.0075,
Mann–Whitney U test, N  10 mice per genotype, Fig. 7D). In
the same line, licking behavior after S1P injectionwas almost fully
prevented in S1P3
/mice (number of licks S1P3
/  1.35

1.10 vs wt 5.31
 1.53; p 0.0132,Mann–WhitneyU test,N
8mice, Fig. 7E; and licking time for S1P3
/mice 3.13
 2.22 s
vs wt  26.14 
 8.27 s; p  0.0066, N  10 mice per genotype,
Fig. 7F). The absence of S1P-evoked pain-like behavior in
S1P3
/ mice suggests that S1P-induced pain generation is
largely mediated by S1P3 receptors in vivo.
Role of S1P3 receptors in postoperative pain
Because S1P can be released as a consequence of tissue injury, the
incision model of postoperative pain with assessment of respon-
siveness to mechanical and thermal stimuli was used to address
the role of S1P in a more clinically relevant preclinical model
(Pogatzki and Raja, 2003). Plantar incision decreased the PWL in
wt mice from 8.88 
 0.37 s (24 h before incision as baseline) to
4.32 
 0.42 s on postoperative day 1 (Fig. 8A). S1P3
/ mice
showedmarkedly reduced thermal hypersensitivity 24 h after the
incision surgery (PWL 8.14
 0.36 s) compared with wt litter-
mates (PWL  4.32 
 0.42 s, p  0.000012, two-way RM
ANOVAwith post Tukey test,N 8mice per genotype, Fig. 8A).
Likewise, mechanical hypersensitivity was significantly dimin-
ished in S1P3
/ compared with wt mice (p  0.032 for 4 mN,
p 0.000035 for 8 and 16 mN, two-way RM ANOVA with post
Figure 5. Expression of S1P2 and S1P3 receptors in different populations of mice DRG neurons. A, Top, Representative confocal
images of cultured sensory neurons show immunoreactivity for S1P2 receptor subtype present in largemyelinated, NF200
 (blue;
Cy5 anti-mouse Ig) but not in peptidergic or IB-4 binding sensory neurons. A, Bottom, S1P3 immunoreactivity in cultured DRG
neurons colocalizedwith peptidergic, IB-4 binding (IB-4), and large diameter (NF200) sensory neurons. Scale bar, 20m.B,
C, Characterization of S1P-mediated Ca 2 transients in SNS-S1P1
/ sensory neurons. Typical ratiometric Ca 2 recordings from
S1P1
fl/fl and SNS-S1P1
/ sensory neurons revealed no difference in the magnitude of the S1P-induced Ca 2 responses (1M
S1P, 10 s). n.s., Not significant ( p 0.05).
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Tukey test, N  8 mice per genotype, Fig. 8B). At later time
points, both mouse strains recovered similarly to baseline. These
results suggest that S1P via S1P3 receptor has a critical role in
postoperative pain.
Together with our reported results in a
cellular model of nociception and the
findings obtained in humans, this study
provides data supporting the hypothesis
that S1P-induced activation of S1P3 re-
ceptor and a GPCR-dependent Cl con-
ductance in mice may notably contribute
to acute post-traumatic pain.
Discussion
The sphingolipid S1P is a multifaceted
immune modulator that can act extra-
cellularly in an autocrine or paracrine
manner or intracellularly as a second
messenger molecule (Mitra et al., 2006;
Alvarez et al., 2007; Takabe et al., 2008).
Extracellular and intracellular levels of
S1P are tightly regulated by sphingosine
kinases (SphKs) and S1P degrading en-
zymes (Spiegel and Milstien, 2003; van
Echten-Deckert and Herget, 2006). Acti-
vation of SphK1 is the key event in elevat-
ing S1P levels (Maceyka et al., 2002; Taha
et al., 2006; Alemany et al., 2007). S1P is
deactivated by S1P-phosphatases or de-
graded by S1P-lyase (Pyne and Pyne,
2000; Le Stunff et al., 2004; Bandhuvula
and Saba, 2007). Mice deficient in both
SphK1 and SphK2 are not viable, indicat-
ing an essential cellular requirement for
S1P (Mizugishi et al., 2005).
Chemoattractants, such as TNF or
NGF, can stimulate S1P production in
immune cells, epithelia, and even neurons
(Zhang et al., 2006b; Alemany et al.,
2007), which can release S1P presumably
via the specific multidrug resistance-
associated protein ABCC1 (Mitra et al.,
2006). Although S1P in blood plasmamay
reach up tomicromolar concentrations, it
is largely bound to plasma proteins, and
free active S1P concentrations are proba-
bly very low (Murata et al., 2000; Schmidt
et al., 2006; Ohkawa et al., 2008). How-
ever, high concentrations of free S1P can,
however, arise locally at inflammation
sites and presumably at sites of thrombo-
cyte activation (Mitra et al., 2006;
Hammad et al., 2008; Ulrych et al., 2011).
Together with a previous work of our
group on nociceptor excitation by acti-
vated platelets that can release S1P upon
thromboxane stimulation as it occurs
during acute injury of blood vessels
(Ringkamp et al., 1994; Ulrych et al.,
2011), these findings encouraged us to in-
vestigate the significance of S1P in nocice-
ption. S1P locally induces nociceptor
sensitization and thermal hypersensitiv-
ity, which is largely mediated by S1P1 re-
ceptor expressed in nociceptors (Mair et al., 2011). In the CNS,
the spinal cord analgesic effects have been reported (Coste et al.,
2008). However, a number of reports support a proalgesic action
Figure 6. Role of S1P3 receptor in S1P-mediated neuronal excitability. A, mRNA in situ hybridization demonstrates the expression of S1P3
receptormRNAinpopulationsofsmall-andlarge-diameterneuronsinmouseDRGsections.A,Bottomleft,NosignaloflabelinginDRGsectionsfrom
S1P3
/mice. Right, S1P3 scramble probes (negative control) did not show any noticeable signal in both genotypes. Scale bar, 100m. B,
ImmunohistochemistryrevealedthepresenceofS1P3receptorproteininsmallandlargeneuronsinmurineandhumanDRG.Scalebar,100m.C,
The depolarizing effect of S1Pwas significantly decreased in S1P3
/ sensory neurons.D, Analysis of the percentage of neurons that showed a
Ca2 rise evoked by S1P inwt and S1P3
/ sensory neurons. The number of S1P-responsive neurons in S1P3-deficientmicewas significantly
reduced.E,ThemagnitudeoftheS1P-mediatedCa2 transientswasseverelydiminishedinS1P3
/miceDRGneurons.***p	0.001.
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of S1Pwhen acting at peripheral nerve ter-
minals via S1P1 (Zhang et al., 2006a,b; Chi
andNicol, 2010; Doyle et al., 2011;Mair et
al., 2011), and even an involvement in
opioid-induced hyperalgesia at spinal
cord level (Muscoli et al., 2010). In addi-
tion to the S1P1-mediated proalgesic ac-
tion, we observed activation of a slowly
activating and deactivating inward cur-
rent in the majority of neurons that were
exposed to S1P, and this issue was ad-
dressed in the present study. S1P induced
a membrane depolarization, which in ap-
proximately two thirds of sensory neu-
rons was sufficient to evoke action
potentials in vitro, and spontaneous pain-
like behavior in vivo inmice. In contrast to
the S1P1-mediated thermal sensitization
(Mair et al., 2011), the excitatory effect did
not require TRPV1 (data not shown) but
still was mediated by a GPCR. In general,
five metabotropic S1P receptors are
known up to date (Spiegel and Milstien,
2003). Several reports support expression
of S1P1, S1P2, and S1P3 GPCRs in DRG
neurons, whereas expression of S1P4 and
S1P5 is controversially discussed (Chi and
Nicol, 2010; Mair et al., 2011). Primary
afferent neurons in murine DRG are di-
vided into at least three distinct
subclasses: sensory neurons expressing
NF200 giving rise to myelinated neurons
for touch sensation and those being noci-
ceptors. The nociceptor population can
be subdivided in neurons expressing neuro-
peptides, especially calcitonin gene-related
peptide-positive, and nonpeptidergic neu-
rons, which express binding sites for I-B4
(isolectin B4, I-B4 neurons). In a re-
cently published work by our group, we
only found evidence of expression of
S1P1, S1P2, and S1P3 receptors in mice
DRG neurons (Mair et al., 2011). S1P1 re-
ceptors were mainly expressed by I-B4
nociceptors butwere also present in a sub-
population of calcitonin gene-related
peptide-positive neurons (Mair et al.,
2011). In contrast, S1P2 receptor immu-
noreactivity is dominant in neurons ex-
pressing the large nonnociceptive neuron
marker NF200. Last, with a combination of in situ hybridization
and indirect immune fluorescence, our current results demon-
strated that S1P3 receptors were most widely distributed and
present in virtually all neurons of all neuron types. The S1P
mRNA and protein distribution pattern closely matched the
presence of IS1P (S1P current) in virtually all recorded neurons.
Furthermore, IS1P required activation of a GPCR and this sup-
ported the possibility that S1P-induced excitatory effects may be
mediated by S1P3. As expected, the number of S1P responsive
neuronswas strongly reduced, although inmicewith a global null
mutation for S1P3, 20% of neurons responded to S1P with,
however, a small Ca2 transient. This can be explained by a con-
tribution of S1P1 receptor, which is expressed in 20% of sen-
sory neurons (Mair et al., 2011). In vivo, the S1P-induced
spontaneous pain behaviorwas to a large extent abolished inmice
lacking S1P3 suggesting that S1P3 largely mediates nociceptor
excitation by S1P. Moreover, S1P3-deficient mice were largely
protected from thermal and mechanical hyperalgesia induced
after plantar incision, revealing a prominent role of S1P3 receptor
in postoperative pain.
Regarding the nature of S1P-induced currents, several ion
channels may be involved: in particular, lipid sensing is an im-
portant aspect of transient receptor potential canonical (TRPC)
channel biology enabling integrationwith other cellular signaling
systems (Beech, 2012). There are sevenmammalian genes encod-
ing for TRPC channels, of which six are expressed in DRG
Figure 7. Spontaneous pain behavior in SNS-S1P1
/ and S1P3
/mice. The number of flinches (A) and licking response
(B,C) after S1P injection (500M, 15l) into the ipsilateral hindpaw of SNS-S1P1
/mice was not significantly different from
control S1P1
fl/fl mice. N 8–10 mice per genotype. D, A significant reduced flinching response was observed in S1P3
/mice
compared with wt mice. E, F, Licking behavior was almost absent in S1P3
/ mice. N  10 mice per genotype. n.s., Not
significant ( p 0.05). *p	 0.05. **p	 0.01.
Figure 8. Heat andmechanical sensitivity of S1P3
/ andwt littermates after plantar incision. A, In wtmice, plantar incision
induced a significant decrease ofwithdrawal latency (PWL) in response to a noxious heat stimulus at the incision site. The decrease
was significantly reduced in the S1P3
/ mice 24 h after plantar incision. B, Likewise, mechanical response frequency was
significantly lower in S1P3
/ versus wt mice on postoperative day 1. *p	 0.05. ***p	 0.001.
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neurons (Zhu et al., 1996; Montell et al., 2002; Kress et al., 2008;
Talavera et al., 2008). TRPC1 and TRPC5 sense the presence of
S1P and contribute to S1P effects onCa2 homeostasis in a num-
ber of cells (Formigli et al., 2009; Beech, 2012). TRPC1 together
with C3 and C6 are the most abundant in DRG cells (Kress et al.,
2008), and S1P-induced activation of TRPC1 but also TRPC5
could contribute to Ca2 transients after neuron exposure to S1P
in the current study. In contrast to, for example, endothelial cells
where S1P promotes endothelial junctional integrity by activat-
ing the release of endoplasmic reticulum-Ca2 (Mehta et al.,
2005), Ca2 transients in the current study fully depended on the
presence of extracellular Ca2, suggesting the Ca2 influx as a
main source of intracellular Ca2 increase possibly via TRPC1 or
TRPC5. However, S1P-induced currents were unaltered in
voltage-clamp recordings using nominally “cation free” solution,
and this, together with reversal potential shifts observed with
variation of extracellular Cl concentrations (data not shown),
strongly supports the idea that IS1P in DRG neurons is probably a
Cl conductance. Like lysophosphatidic acid, S1P activates Cl
currents in keratinocytes and fibroblasts (Postma et al., 1996;
Wang et al., 2002). Mature sensory neurons express cation-Cl
cotransporters and maintain high intracellular Cl concentra-
tions (Mao et al., 2012). Inflammatory mediators and kinases
regulate these cotransporters under inflammatory conditions,
and activation of Cl conductances results in neuron excitation
rather than inhibition as generally observed inmature neurons in
the brain (Funk et al., 2008; Delpire and Austin, 2010). Because
S1P induces increases in [Ca2]i, members of the TMEM16 ion
channel subfamily may contribute to S1P-activated Cl conduc-
tance (Yang et al., 2008). Although activation of TMEM16/ANO1
amplifies depolarization and thereby may increase Ca2 influx
(Cho et al., 2012), our observation that S1P-induced Ca2 tran-
sients were fully inhibited with the Cl channel blocker NFA
does not support this possibility: In our experiments, Ca2 tran-
sients in response to S1P were probably evoked by S1P-induced
activation of a Cl conductance and membrane depolarization
and consecutive activation of voltage-gated Ca2 currents as a
source of Ca2 influx.
Direct activation of Cl channels by GPCRs has not been
reported so far; however, first evidence for S1P activation of G13
links the RhoA GTPase pathway with activation of intracellular
Cl channels (Postma et al., 2001; Ponsioen et al., 2009). These
reports are consistent with the substantial inhibition of S1P-
induced currents andCa2 influxes in the presence of the general
Cl channel blocker NFA in the present study and support the
idea that a depolarizing Cl conductance is activated by S1P in
sensory neurons. The clinical relevance of a Cl current for acti-
vation of nociceptive primary afferents and the ensuing axon
reflex flare response has been shown in human skin by blocking
the NaK2Cl cotransporter, which reduced histamine-evoked
itch-and-flare responses (Willis et al., 2004).
In conclusion, we show, for the first time to our knowledge,
that the S1P-induced activation of an excitatory Cl conduc-
tance downstream of S1P3 receptor is a significant inducer of
peripheral nociception in mice and humans. Together with
recent results, the concept that modulation of S1P receptors
can be used to direct neuroprotective and regenerative actions
in the CNS is supported, as well as its anti-inflammatory ef-
fects (Soliven et al., 2011). Thus, our study supports the idea to
extend the pharmacological targeting of S1P receptors into
pain therapy.
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